Multi-faceted Determinants For Achieving Glycemic Control: The International Diabetes Management Practice Study (IDMPS)

  1. Juliana C. N. Chan, MD (jchan{at}cuhk.edu.hk)a,
  2. Juan Jose Gagliardino, PhDb,
  3. Sei Hyun Baik, PhDc,
  4. Jean-Marc Chantelot, MDd,
  5. Sandra R. G. Ferreira, PhDe,
  6. Nicolae Hancu, PhDf,
  7. Hasan Ilkova, PhDg,
  8. Ambady Ramachandran, PhDh and
  9. Pablo Aschner, MDi on behalf of the IDMPS investigators
  1. aDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, The Prince of Wales Hospital, Shatin, Hong Kong SAR, China
  2. bCENEXA (UNLP-CONICET), PAHO/WHO Collaborating Centre for Diabetes, School of Medicine, National University of La Plata, La Plata, Buenos Aires, Argentina
  3. cDepartment of Internal Medicine, Korea University Guro Hospital, Seoul, Republic of Korea
  4. dDepartment of ITC Medical Affairs, sanofi-aventis, Paris, France
  5. eDepartment of Preventive Medicine, Federal University of Sao Paulo, Sao Paulo, Brazil
  6. fDiabetes Center and Clinic, Iuliu Hatieganu University of Medicine, Cluj-Napoca, Romania
  7. gDepartment of Internal Medicine, Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey
  8. hIndia Diabetes Research Foundation, Dr. A. Ramachandran's Diabetes Hospitals, Chennai, India
  9. iEndocrinology Unit, Javeriana University, Bogotá, Colombia

    Abstract

    Objectives: The International Diabetes Mellitus Practice Study (IDMPS) is a 5-year survey documenting changes in diabetes practice in developing regions.

    Research and methods: Logistic regression analysis was used to identify factors for achieving HbA1c <7% in 11799 patients (1898 type 1 and 9901 type 2) recruited by 937 physicians from 17 countries in Eastern Europe (EE; N=3519), Asia (n=5888), Latin America (LA; N=2116) and Africa (N=276).

    Results: 22% of type 1 and 36% of type 2 diabetic patients never had HbA1c measurements. In those with values for HbA1c, blood pressure (BP) and LDL-cholesterol (LDL-C), 7.5% of type 1 (n=696) and 3.6% of type 2 patients (n=3896) attained all 3 recommended targets (BP<130/80 mmHg, LDL-C<100 mg/dL and HbA1c<7%). Self monitoring of blood glucose (SMBG) was the only predictor for achieving the HbA1c goal in type 1 diabetes (odds ratios: Asia 2.24, LA 3.55 and EE 2.42). In type 2 diabetes, short disease duration (Asia 0.97; LA 0.97; EE 0.82) and treatment with few oral glucose lowering drugs (OGLD; Asia: 0.64; LA: 0.76; EE: 0.62) were predictors. Other region-specific factors included lack of microvascular complications and old age in LA and Asia; health insurance coverage and specialist care in LA; lack of obesity and self-adjustment of insulin dosages in Asia; training by a diabetes educator, SMBG in patients who self-adjusted insulin and lack of macrovascular complications in EE.

    Conclusions: In developing countries, factors pertinent to patients, doctors, and health care systems all impact on glycemic control.

    Footnotes

      • Received February 29, 2008.
      • Accepted November 6, 2008.